Navigation Links
Biodel to Report First Quarter Fiscal Year 2011 Financial Results on February 3, 2011
Date:1/31/2011

DANBURY, Conn., Jan. 31, 2011 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) will issue its first quarter fiscal year 2011 financial results on February 3, 2011.  Following the release of the company's financial results, Biodel's senior management will host a conference call to discuss the results and provide an update on the company's progress.February 3, 2011 schedule:4:00 pm EST:

Q1 fiscal year 2011 results will be distributed4:15 pm EST:

Conference call participants should dial:+1 ( 877 ) 303 - 8028 (United States) or+1 ( 760 ) 536 - 5167 (International)4:30 pm EST:

Conference call beginsInterested parties may access a live audio webcast of the conference call in the investor section of Biodel's website at www.biodel.com.  The audio webcast will be archived and available for replay through the website.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients.  We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles.  For further information regarding Biodel, please visit the company's website at www.biodel.com.

BIOD-G

The Trout Group LLCSeth D. Lewis, +1-646-378-2952
'/>"/>

SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
2. Biodel Announces Retirement of Dr. Solomon Steiner as Chief Scientific Officer
3. Biodel Reports Fourth Quarter and Fiscal Year 2010 Financial Results
4. Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting
5. Biodel to Present Data from Product Development Programs at 2010 Diabetes Technology Meeting
6. Biodel Awarded $1.2 Million in Therapeutic Discovery Research Grants From IRS
7. FDA Issues Complete Response Letter to Biodel Regarding New Drug Application for Linjeta™
8. Biodel to Present at Upcoming Conferences
9. Biodel Reports Research Progress in Poster Session on Short-Acting Insulins at 46th EASD Annual Meeting
10. Biodel Appoints Arthur Urciuoli to its Board of Directors
11. Biodel to Raise $9.4 Million Through Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... 2017 This morning,s research ... stocks: The Medicines Co. (NASDAQ: MDCO), Ironwood Pharmaceuticals ... and Supernus Pharmaceuticals Inc. (NASDAQ: SUPN ... space which is governed by the same governing ... the industry are wholesalers, retailers, pharmacies, and benefit ...
(Date:3/28/2017)... , March 28, 2017 RXi Pharmaceuticals ... innovative therapeutics that address significant unmet medical needs, ... from the Japan Patent Office (JPO) for the ... growth factor (CTGF) for the treatment or prevention ... skin fibrosis and proliferative retinopathy (Japanese Patent #: ...
(Date:3/27/2017)... March 27, 2017 The National University ... and data analytics company, signed a Memorandum of ... healthcare delivery in the region. ... Health Research and Technology (BIGHEART) at NUS and ... topics related to healthcare IT and medical device ...
Breaking Medicine Technology:
(Date:3/28/2017)... , ... March 29, 2017 , ... Dr. Isabella Wentz, ... launching a 9-part video series titled The Thyroid Secret. Dr. Wentz talked about journey ... which emphasizes the fact that medication IS NOT the only solution to deal with ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... medical society dedicated to advancing the science and clinical practice of radiosurgery, ... RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data collection ...
(Date:3/28/2017)... ... 28, 2017 , ... Z-Medica, LLC, a leading developer and ... (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to 1,000 ... efforts by the American College of Surgeons, U.S. Department of Defense, Department of ...
(Date:3/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce that ... Mr. Still was selected through a careful months-long search by the RBMA Board of ... our members, has been a part of building the RBMA since 1992,” said RBMA ...
(Date:3/28/2017)... ... 28, 2017 , ... Qualidigm , the mission-driven national ... a new, more expansive office space in order to accommodate its growing number ... office building in Wethersfield, Conn. located at 936 Silas Deane Highway and immediately ...
Breaking Medicine News(10 mins):